Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Kohli, M; Li, J; Du, MJ; Hillman, DW; Dehm, SM; Tan, W; Carlson, R; Campion, MB; Wang, LG; Wang, LW; Zhang, HJ; Zhang, P; Kilari, D; Huang, CC; Wang, L

Kohli, M (reprint author), Mayo Clin, Div Med Oncol, Dept Oncol, Rochester, MN 55905 USA.; Wang, L (reprint author), Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.; Wang, L (reprint author), Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA

PROSTATE CANCER AND PROSTATIC DISEASES, 2018; 21 (3): 411

Abstract

Background The prognostic significance of plasma cell-free DNA (cfDNA) androgen receptor amplification (ARamp) in metastatic castration-resistant pros......

Full Text Link